EGFR and cancer: Further analysis revealed that adenocarcinoma had a strong association with the expression of Exon 19 deletion mutation in EGFR-positive patients (p=0.04), but the gender, smoking status, occupational exposure, and family history of any cancer did not exhibit any significant association.